Optimized TracrolimuS and MMF for HLA Antibodies after Renal Transplantation (the OuTSMART study): a randomized controlled clinical trial to determine if a combined screening/treatment programme can prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies

Dorling, Anthony (Primary Investigator)
Murphy, Caroline (Co-Investigator)
Peacock, Janet (Co-Investigator)
Rebollo-Mesa, Irene (Co-Investigator)
Vaughan, Robert (Co-Investigator)

Project: Research

Status	Finished
Effective start/end date	1/12/2012 → 31/05/2022

Collaborative partners

King's College London (lead)
Central Manchester University Hospitals NHS Foundation Trust
Leeds and York Partnership NHS Foundation Trust
GSTT Guy's and St Thomas' NHS Foundation Trust
Barts Health NHS Trust
UCL University College London
University Hospitals Birmingham NHS Foundation Trust

Funding

NIHR National Institute For Health & Care Research: £246,325.00
NIHR National Institute For Health & Care Research: £2,362,490.00